|
|
Volumn 19, Issue 5, 2005, Pages 689-695
|
|
Development of a liquid chromatography/tandem mass spectrometry assay for the quantification of PM00104, a novel antineoplastic agent, in mouse, rat, dog, and human plasma
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ASSAYS;
CALIBRATION;
LIQUID CHROMATOGRAPHY;
MASS SPECTROMETRY;
PLASMA (HUMAN);
RATS;
ANTINEOPLASTIC AGENTS;
CALIBRATION STANDARD;
CONTROL LEVEL;
DOG PLASMA;
HUMAN PLASMAS;
INTERNAL STANDARDS;
LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY ASSAYS;
MICE PLASMA;
RAT PLASMA;
SENSITIVE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY;
QUALITY CONTROL;
ANTINEOPLASTIC AGENT;
PM 00104;
UNCLASSIFIED DRUG;
ACCURACY;
ARTICLE;
CALIBRATION;
CORRELATION COEFFICIENT;
DRUG BLOOD LEVEL;
HUMAN;
LIQUID CHROMATOGRAPHY;
MEASUREMENT;
NONHUMAN;
PLASMA;
SENSITIVITY AND SPECIFICITY;
TANDEM MASS SPECTROMETRY;
VALIDATION PROCESS;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BLOOD CHEMICAL ANALYSIS;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
DOGS;
HUMANS;
MICE;
RATS;
REPRODUCIBILITY OF RESULTS;
SENSITIVITY AND SPECIFICITY;
SPECIES SPECIFICITY;
SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;
TETRAHYDROISOQUINOLINES;
|
|
EID: 14744306773
PISSN: 09514198
EISSN: None
Source Type: Journal
DOI: 10.1002/rcm.1848 Document Type: Article |
|
Times cited : (12)
|
|
References (4)
|
